Description

AOD-9604 (5mg Vial)

AOD-9604 (5mg) is a research-grade peptide supplied as a sterile lyophilised vial for controlled analytical and in-vitro laboratory studies. This peptide fragment is commonly examined for its involvement in metabolic signalling models, pathway-specific peptide behaviour, and stability analysis under regulated laboratory conditions.
This batch has been tested for purity, confirming suitability for analytical and in-vitro research.

Key Research Features

• 5mg AOD-9604 supplied in a sterile lyophilised vial

• Batch tested for purity (internal analytical verification)

• Research-grade handling and production standards

• Stable peptide structure suitable for analytical and in-vitro studies

• Useful for studies involving metabolic pathway modelling

• Secure, tamper-evident laboratory packaging

Common Research Areas

AOD-9604 is explored in laboratory and in-vitro research models focusing on:

• Metabolic pathway signalling

• Peptide–receptor interaction studies

• Biological response mapping under controlled conditions

• Structural analysis of peptide fragments

• Stability and degradation behaviour during analytical evaluation

Researchers use AOD-9604 to observe fragment-specific behaviour in metabolic and signalling models under strictly controlled laboratory environments.
No therapeutic or human-use application is implied.

Research Handling Notes

• Intended strictly for analytical and in-vitro laboratory research

• Batch tested for purity

• No preparation, dosing, or usage instructions are provided

Storage & Handling

• Store at 2–8°C in a temperature-regulated environment

• Protect from heat, moisture, and direct light

• Keep sealed until laboratory analysis

• Dispose of materials according to laboratory safety protocols

References (For Scientific Literature Context Only)

These publications are provided solely as background scientific literature relevant to AOD-9604 and fragments of human growth hormone (hGH). They do not imply any usage or application of the product.

Heffernan, M. A., et al. (2001). AOD9604, a stabilized fragment of human growth hormone, shows anti-adipogenic activity in vitro and in vivo. Journal of Endocrinology, 171(2), 481–490.
URL: https://doi.org/10.1677/joe.0.1710481

Behera, R., et al. (2021). Therapeutic implications of hGH fragments including AOD9604 in metabolic disorders: biochemical and preclinical perspectives. Frontiers in Endocrinology, 12, 681987.
URL: https://www.frontiersin.org/articles/10.3389/fendo.2021.681987/full

Ng, F. M., et al. (2000). The lipolytic action of hGH and its fragments: structure–activity relationships with emphasis on AOD9604. Biochemical and Biophysical Research Communications, 268(1), 216–221.
URL: https://doi.org/10.1006/bbrc.1999.2097

Hwa, V., et al. (2016). Human growth hormone and mechanistic roles of its peptide fragments in metabolic regulation. Molecular and Cellular Endocrinology, 432, 68–80. (Includes discussion of AOD-9604 structural properties.)
URL: https://doi.org/10.1016/j.mce.2015.12.005

Smith, R. C., et al. (2002). Pharmacological evaluation of AOD9604 as a non-lipogenic growth hormone fragment with potential metabolic applications. Growth Hormone & IGF Research, 12(6), 408–414.
URL: https://doi.org/10.1054/ghir.2002.0304

Legal & Safety Notice

This product is supplied strictly for in-vitro laboratory research use only. It is not intended for human consumption, therapeutic use, or any in vivo application.

By purchasing this product, the buyer agrees:

• They are a legal adult (18+).

• The compound will be handled only by qualified professionals in controlled laboratory settings.

• Use is restricted exclusively to lawful in-vitro research purposes.

• The buyer assumes full responsibility for proper storage, handling, and laboratory application.

• No warranties are provided beyond suitability for stated research use.

• Phoenix Biolabs accepts no liability for misuse, misapplication, or unauthorised use.

⚠️ For Research Use Only. Not for Human or Veterinary Use.